Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Oseltamivir Biotin conjugate 1 | Oseltamivir Biotin conjugate 1 is a novel conjunction used for the targeted delivery of Oseltamivir, a drug for treating influenza caused by H1N1 and H3N2 strains. With the addition of Biotin, this conjugate provides selective binding to cells expressing biotin receptors, enhancing drug efficiency and reducing off-target effects. Group: Pharmaceutical. CAS No. 1612755-43-7. Pack Sizes: 10 mg. Product ID: B1370-410017. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Oseltamivir-[d5] Hydrochloride | Labelled Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-004456. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity C | Oseltamivir EP Impurity C is the active metabolite of oseltamivir. Oseltamivir, also called as GS 4071 or Ro 64-0802, is an antiviral drug that competitively inhibits neuraminidase A and B (IC50 = 0.1 to 4.9 nM). Uses: A metabolite of oseltamivir. Group: Pharmaceutical. CAS No. 187227-45-8. Pack Sizes: 50 mg. Product ID: B0084-172019. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity D | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 1346604-18-9. Pack Sizes: 10 mg. Product ID: B2694-478420. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity F | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 1052063-37-2. Pack Sizes: 25 mg. Product ID: B2694-478419. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity G | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 956267-10-0. Pack Sizes: 25 mg. Product ID: B2694-478418. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir Impurities | Oseltamivir Impurities, critical in the pharmaceutical realm, serve as essential reference standards for quality control in antiviral drug development. These impurities help ensure the purity and safety of medications like oseltamivir, utilized primarily for treating influenza types A and B, safeguarding patients against potential side effects. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir Phosphate | Oseltamivir phosphate (Tamiflu) is a competitive neuraminidase inhibitor. The prodrug oseltamivir phosphate (Tamiflu) is itself not virally effective. Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 204255-11-8. Pack Sizes: 10 g. Product ID: B0046-464103. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Desacetyl 5-Azido Oseltamivir | N-Desacetyl 5-Azido Oseltamivir is an intermediate of Oseltamivir, which can be used in COVID19-related research. Uses: Intermediate in the production of oseltamivir. Group: Pharmaceutical. CAS No. 204255-04-9. Pack Sizes: 100 mg. Product ID: B2694-118725. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl bromide | 2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl bromide is an indispensible player in the antiviral drug developing and synthesis process such as Oseltamivir. Group: Pharmaceutical. CAS No. 572-09-8. Pack Sizes: 100 g. Product ID: B1370-375351. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Baloxavir | Baloxavir marboxil is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy in a wide range of influenza viruses, including in vitro activity against oseltamivir-resistant strains and avian strains (H7N9, H5N1) in non-clinical studies. Baloxavir is a polymerase acidic, cap-dependent, endonuclease inhibitor that is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours. It blocks viral proliferation by binding to one of two endonuclease binding sites, inhibiting the initiation of mRNA synthesis for both influenza A and influenza B strains. Baloxavir can interact with polyvalent cation-containing products, which can decrease its plasma concentration. Group: Pharmaceutical. CAS No. 1985605-59-1. Pack Sizes: 50 mg. Product ID: B2692-008721. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Baloxavir-[d4] | Baloxavir-[d4] is an isotope compound of Baloxavir. Baloxavir marboxil is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy in a wide range of influenza viruses, including in vitro activity against oseltamivir-resistant strains and avian strains (H7N9, H5N1) in non-clinical studies. Baloxavir is a polymerase acidic, cap-dependent, endonuclease inhibitor that is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours. It blocks viral proliferation by binding to one of two endonuclease binding sites, inhibiting the initiation of mRNA synthesis for both influenza A and influenza B strains. Baloxavir can interact with polyvalent cation-containing products, which can decrease its plasma concentration. Group: Pharmaceutical. CAS No. 2415027-80-2. Pack Sizes: 2 mg. Product ID: BLP-003387. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Baloxavir marboxil | Baloxavir marboxil is a first-in-class, one-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy in a wide range of influenza viruses, including in vitro activity against oseltamivir-resistant strains and avian strains (H7N9, H5N1) in non-clinical studies. Baloxavir is a polymerase acidic, cap-dependent, endonuclease inhibitor that is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours. It blocks viral proliferation by binding to one of two endonuclease binding sites, inhibiting the initiation of mRNA synthesis for both influenza A and influenza B strains. Baloxavir can interact with polyvalent cation-containing products, which can decrease its plasma concentration. Group: Pharmaceutical. CAS No. 1985606-14-1. Pack Sizes: 50 mg. Product ID: B2692-291710. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
